How should the comp committee evaluate sales leaders in 2027?
Direct Answer
In 2027, the comp committee evaluation of sales leaders uses a five-dimension framework: (1) revenue performance — quota attainment, ACV, NRR, gross margin (weighted 40-50%); (2) strategic execution — ICP refinement, segment expansion, comp plan health, talent decisions (20-25%); (3) organizational health — AE retention, manager span, ramp time, AE satisfaction (15-20%); (4) forecast quality — accuracy, transparency, predictability (10-15%); (5) leadership presence — board communication, executive partnership, talent magnet status (5-10%).
The operator who owns the framework is the Board Comp Committee Chair in partnership with CEO and CHRO, with CRO comp benchmarked against peer companies via Radford (Aon), Alexander Group, or WorldatWork. The standard 2027 CRO compensation structure is $400K-$700K base, $400K-$800K target bonus (paid quarterly + annual true-up), and $4M-$25M equity grant over 4 years vesting — totaling $900K-$1.8M annual cash + $1M-$6.25M annual equity.
Pavilion's 2027 CRO Compensation Benchmark (n=287 publicly-disclosed and surveyed CRO comp packages) found that 74% of CROs received bonus payouts in the 80-120% of target range — with above-130% payouts concentrated in explosive growth-stage companies and below-70% payouts triggering CRO replacement discussions within 2 quarters.
The defensible 2027 evaluation architecture uses a quarterly review cadence with an annual reset rather than purely annual reviews. Quarterly reviews surface execution issues early; annual resets recalibrate strategic targets. The comp committee meets 3-4 times per year to review CRO performance against the five-dimension scorecard, calibrate bonus payouts, and adjust forward-looking targets.
Forrester's Q2 2027 Sales Leadership Compensation Study found that comp committees using the quarterly + annual cadence retained 88% of high-performing CROs versus 64% retention for committees using annual-only reviews — primarily because quarterly reviews allow early intervention when CROs hit rough patches, while annual-only reviews force binary stay/leave decisions at year-end.
The CEO + Comp Committee Chair co-own the framework; HR Committee provides administrative support.
1. The Five-Dimension Framework
1.1 Revenue performance (40-50%)
Quota attainment, ACV trajectory, NRR, gross margin, sales efficiency (CAC payback, magic number). The largest weight by far. 2027 weighting has shifted toward NRR and efficiency — versus 2022 when raw ARR growth dominated.
1.2 Strategic execution (20-25%)
ICP refinement progress, segment expansion success, comp plan health, talent decisions (hires, fires, promotions), GTM tooling investments. Measured against the strategic plan presented at annual board meeting.
1.3 Organizational health (15-20%)
AE voluntary attrition rate, manager span of control, time-to-quota for new hires, AE satisfaction (eNPS or equivalent), diversity metrics. 2027 emphasis on this dimension increased materially as boards recognized that healthy orgs outperform short-term performance optimization.
1.4 Forecast quality (10-15%)
Forecast accuracy (within X% of commit), forecast transparency (no surprises at end of quarter), forecast predictability across multiple quarters. Boards increasingly weight this dimension as AI-driven forecasting raises the accuracy baseline.
1.5 Leadership presence (5-10%)
Board communication effectiveness, executive partnership (CEO, CFO, CPO alignment), talent magnet status (ability to recruit senior talent), industry presence. Smallest weight but disproportionate to retention decisions — boards rarely fire CROs they personally admire and trust.
2. The 2027 CRO Compensation Benchmarks
Pavilion 2027 CRO Compensation Benchmark (n=287 packages):
| ARR Band | Base | Target Bonus | Annual Cash | Equity (4-yr) |
|---|---|---|---|---|
| $10M-$25M ARR | $325K | $325K | $650K | $1.5M-$4M |
| $25M-$50M | $375K | $375K | $750K | $2.5M-$8M |
| $50M-$100M | $450K | $450K | $900K | $4M-$12M |
| $100M-$250M | $550K | $550K | $1.1M | $6M-$18M |
| $250M-$500M | $625K | $675K | $1.3M | $10M-$22M |
| $500M-$1B | $700K | $800K | $1.5M | $15M-$30M |
| $1B+ | $800K | $1.0M | $1.8M | $20M-$50M |
2.1 The bonus payout distribution
74% of CROs receive bonus payouts in 80-120% of target. Below 70% triggers replacement discussions within 1-2 quarters. Above 130% concentrated in explosive growth stages (often pre-IPO with equity acceleration).
2.2 The equity refresh cadence
Annual equity refresh of 25-35% of original grant is the 2027 norm. Without refresh, CROs become economically misaligned with company trajectory and flight risk increases.
3. The Quarterly Evaluation Architecture
3.1 The CRO self-assessment
CRO completes a self-assessment against the 5-dimension scorecard before the comp committee meeting. Surfaces honest CRO perspective and demonstrates self-awareness. CROs who can articulate their own weaknesses retain comp committee confidence at much higher rates than those who only highlight strengths.
3.2 The CEO pre-brief
CEO pre-briefs comp committee chair on CRO performance and proposed bonus calibration. Aligns CEO and comp committee before the formal meeting, preventing surprises.
4. The Annual Reset Cadence
4.1 The equity refresh signal
Equity refresh size signals comp committee confidence. 35%+ refresh = strong confidence; 15-25% refresh = standard maintenance; 5-10% refresh = warning signal. CROs who get warning-signal refreshes typically have 12-18 months to recover or face replacement.
4.2 The retention RSU
Some 2027 packages include retention RSUs vesting at 3-5 year cliffs. Bridge Group 2027: retention RSUs increase CRO tenure by median 18 months versus packages without them.
5. The Real Operator Numbers For 2027
Pavilion 2027 CRO Compensation Benchmark (n=287 packages):
- % of CROs receiving 80-120% bonus payout: 74%
- % receiving above 130% (over-attainment): 12%
- % receiving below 70% (warning signal): 14%
- % of warning-signal CROs replaced within 1-2 quarters: 64%
- CRO retention with quarterly + annual review cadence: 88%
- CRO retention with annual-only review: 64%
- Median CRO tenure (2024-2026 vintage): 22 months
- Median CRO tenure with strong comp + governance: 38 months
5.1 The Forrester observation
Forrester's Q2 2027 Sales Leadership Compensation Study noted: "Quarterly compensation review with annual reset has emerged as the 2027 best practice. Comp committees that wait until year-end to surface concerns face binary stay/leave decisions; comp committees that review quarterly can intervene early and retain high-potential CROs through rough patches."
5.2 The Bridge Group observation
Bridge Group's 2027 CRO Tenure Study noted: "The five-dimension scorecard has become standard in 2027. Comp committees that evaluate on revenue alone consistently lose high-performing CROs who excel on strategic and organizational dimensions but face revenue volatility. The multi-dimensional view rewards the right behaviors."
6. The Common Failure Modes
Failure 1: Revenue-only evaluation. Misses strategic and organizational dimensions; rewards short-term thinking.
Failure 2: Annual-only reviews. Binary year-end decisions instead of early intervention.
Failure 3: No CRO self-assessment. Misses CRO perspective; reduces self-awareness signal.
Failure 4: No equity refresh. CROs become economically misaligned; flight risk climbs.
Failure 5: Comp committee surprise at board meeting. CEO must pre-brief committee chair to prevent dynamic where comp committee and CEO appear misaligned.
FAQ
Q: Should the comp committee meet with the CRO directly or only through the CEO? Both — annually with CRO directly; quarterly through CEO. Annual CRO 1:1 with comp committee chair builds direct relationship; quarterly CEO-mediated reviews preserve CEO authority and operational independence.
Q: How do we handle a CRO who's performing well but disagrees with the comp committee? Comp committee chair owns the relationship. Direct 1:1 conversation surfacing the disagreement is preferable to letting it fester. Most disagreements stem from misaligned expectations that can be reset.
Q: Should CRO comp be benchmarked against peer companies? Yes — annually via Radford, Alexander Group, or WorldatWork. Without benchmarking, CRO comp drifts out of market; competitive recruiting becomes easier for the CRO's competitors.
Q: What about retention bonuses for high-performing CROs? Increasingly common in 2027. Typical structure: 2-3 year retention bonus of 50-100% of annual cash vesting at the milestone. Bridge Group 2027: retention bonuses extend CRO tenure by median 14 months.
Q: How does comp committee evaluation change during M&A? Add M&A-specific scorecard dimensions: integration milestones, retention of acquired talent, revenue continuity. Many CROs receive M&A retention bonuses equivalent to 75-150% of annual cash vesting at integration milestones.
Sources
- Pavilion, "2027 CRO Compensation Benchmark" (n=287 packages)
- Forrester, "Q2 2027 Sales Leadership Compensation Study"
- Gartner, "2027 Board-Level CRO Effectiveness Research"
- Bridge Group, "2027 CRO Tenure Study"
- Radford / Aon, "2027 Executive Compensation Survey"
- Alexander Group, "2027 Sales Leadership Compensation"
- WorldatWork, "2027 Executive Pay Survey"
- ScaleVP, "2027 CRO Leadership Benchmarks"